The event will feature presentations by key opinion leaders John Sutcliffe MBChB FRCS(Ed) FRCS(SN) (London Spine Clinic) and Andrew A. Sama, MD (Hospital for Special Surgery, Weill Cornell Medical College), who will discuss the scientific rationale of Kuros’s lead programs, Fibrin/PTH and MagnetOS, as well the treatment landscape in both EU and US.